ES8400438A1 - Procedimiento para preparar derivados de (3h)-imidazo(5,1-d)-1,2,3,5-tetrazin-4-ona. - Google Patents

Procedimiento para preparar derivados de (3h)-imidazo(5,1-d)-1,2,3,5-tetrazin-4-ona.

Info

Publication number
ES8400438A1
ES8400438A1 ES515176A ES515176A ES8400438A1 ES 8400438 A1 ES8400438 A1 ES 8400438A1 ES 515176 A ES515176 A ES 515176A ES 515176 A ES515176 A ES 515176A ES 8400438 A1 ES8400438 A1 ES 8400438A1
Authority
ES
Spain
Prior art keywords
carbon atoms
groups
tetrazin
imidazo
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515176A
Other languages
English (en)
Spanish (es)
Other versions
ES515176A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of ES515176A0 publication Critical patent/ES515176A0/es
Publication of ES8400438A1 publication Critical patent/ES8400438A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES515176A 1981-08-24 1982-08-23 Procedimiento para preparar derivados de (3h)-imidazo(5,1-d)-1,2,3,5-tetrazin-4-ona. Expired ES8400438A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24

Publications (2)

Publication Number Publication Date
ES515176A0 ES515176A0 (es) 1983-11-01
ES8400438A1 true ES8400438A1 (es) 1983-11-01

Family

ID=10524141

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515176A Expired ES8400438A1 (es) 1981-08-24 1982-08-23 Procedimiento para preparar derivados de (3h)-imidazo(5,1-d)-1,2,3,5-tetrazin-4-ona.

Country Status (29)

Country Link
JP (1) JPS5843975A (en:Method)
KR (1) KR890000094B1 (en:Method)
AT (1) AT380256B (en:Method)
AU (1) AU571430B2 (en:Method)
BE (1) BE894175A (en:Method)
CA (1) CA1197247A (en:Method)
CH (1) CH655114A5 (en:Method)
DE (2) DE3231255A1 (en:Method)
DK (1) DK161147C (en:Method)
ES (1) ES8400438A1 (en:Method)
FI (1) FI73434C (en:Method)
FR (1) FR2511679A1 (en:Method)
GB (1) GB2104522B (en:Method)
GE (1) GEP19960641B (en:Method)
GR (1) GR76863B (en:Method)
HU (1) HU186107B (en:Method)
IE (1) IE53408B1 (en:Method)
IL (1) IL66606A (en:Method)
IT (1) IT1152505B (en:Method)
LT (1) LT2436B (en:Method)
LU (1) LU84347A1 (en:Method)
LV (2) LV5511A3 (en:Method)
NL (2) NL192739C (en:Method)
NZ (1) NZ201668A (en:Method)
OA (1) OA07174A (en:Method)
SE (1) SE448543B (en:Method)
SU (1) SU1447284A3 (en:Method)
UA (1) UA5971A1 (en:Method)
ZA (1) ZA826120B (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
GR78688B (en:Method) * 1982-08-17 1984-09-27 May & Baker Ltd
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
DE69636837T2 (de) * 1995-09-25 2007-10-25 Sanofi-Aventis U.S. Llc 1,2,4-benzotriazinoxid-formulierungen
BRPI0417117A (pt) 2003-12-30 2007-03-06 Chemagis Ltd temozolomida cristalizada, processo de preparação de temozolomida cristalizada, composição farmacêutica, método de produção de medicamento contendo temozolomida e método de tratamento de uma condição médica para a qual a termozolomida é benéfica
ES2552338T3 (es) 2005-01-21 2015-11-27 Astex Therapeutics Limited Compuestos farmacéuticos
AR060635A1 (es) 2006-04-27 2008-07-02 Banyu Pharma Co Ltd Derivados de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona, composiciones farmaceuticas que los comprenden y su uso en el tratamiento del cancer
JP2008081492A (ja) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd オーロラａ選択的阻害作用を有する新規アミノピリジン誘導体
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
EP2213673B1 (en) 2007-10-23 2013-06-05 Msd K.K. Pyridone-substituted-dihydropyrazolopyrimidinone derivative
PE20091101A1 (es) * 2007-12-18 2009-07-26 Pharminox Ltd AMIDAS DE ACIDO 3-SUBSTITUIDO-4-OXO-3,4-DIHIDRO-IMIDAZO[5,1-d] [1,2,3,5-TETRACINA-8-CARBOXILICO Y SU EMPLEO
AU2009318790A1 (en) * 2008-11-24 2011-06-23 Reliance Life Sciences Pvt. Ltd. Process for the preparation of tetrazine derivatives
EP2403339B1 (en) 2009-03-06 2017-01-18 Merck Sharp & Dohme Corp. Combination cancer therapy with an akt inhibitor and other anticancer agents
JP2012530775A (ja) 2009-06-23 2012-12-06 ファーミノックス リミテッド ３−置換−８−置換−３Ｈ−イミダゾ［５，１−ｄ］［１，２，３，５−テトラジン−４−オン化合物及びその使用
RU2462466C1 (ru) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Замещенные азоло[1,2,4,5]тетразины - ингибиторы актинобактериальных серин-треониновых протеинкиназ
US20140271657A1 (en) 2011-10-12 2014-09-18 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
SG10201913331VA (en) 2016-03-15 2020-03-30 Oryzon Genomics Sa Combinations of lsd1 inhibitors for use in the treatment of solid tumors
KR101847342B1 (ko) * 2017-05-08 2018-04-11 (주)센텍코리아 웨어러블 체지방 연소량 측정기

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (de) * 1979-08-09 1981-02-26 Basf Ag Azolo- eckige klammer auf 5,1-d eckige klammer zu - eckige klammer auf 1,2,3,5 eckige klammer zu -tetrazin-4-one und verfahren zur herstellung dieser verbindungen

Also Published As

Publication number Publication date
DE19975037I2 (de) 2001-06-13
IE822026L (en) 1983-02-24
FI822921A0 (fi) 1982-08-23
LV5621A3 (lv) 1994-05-10
IE53408B1 (en) 1988-11-09
HU186107B (en) 1985-06-28
FI73434C (fi) 1987-10-09
AU571430B2 (en) 1988-04-21
KR890000094B1 (ko) 1989-03-07
FI822921L (fi) 1983-02-25
FR2511679A1 (fr) 1983-02-25
NL990010I2 (nl) 1999-09-01
AT380256B (de) 1986-05-12
GR76863B (en:Method) 1984-09-04
DK161147B (da) 1991-06-03
IL66606A0 (en) 1982-12-31
IT1152505B (it) 1987-01-07
IT8222938A0 (it) 1982-08-23
CH655114A5 (fr) 1986-03-27
BE894175A (fr) 1983-02-23
GB2104522A (en) 1983-03-09
DK161147C (da) 1991-11-18
DE3231255A1 (de) 1983-03-03
ES515176A0 (es) 1983-11-01
LT2436B (lt) 1994-02-15
NZ201668A (en) 1985-08-16
AU8749382A (en) 1983-03-03
DK377882A (da) 1983-02-25
OA07174A (fr) 1984-04-30
SE8204817L (sv) 1983-02-25
LU84347A1 (fr) 1983-06-07
SE8204817D0 (sv) 1982-08-23
NL192739C (nl) 1998-01-06
GB2104522B (en) 1985-06-12
DE3231255C2 (en:Method) 1992-02-27
NL8203286A (nl) 1983-03-16
SE448543B (sv) 1987-03-02
GEP19960641B (en) 1996-11-15
IL66606A (en) 1987-07-31
JPS5843975A (ja) 1983-03-14
UA5971A1 (uk) 1994-12-29
ATA319182A (de) 1985-09-15
CA1197247A (fr) 1985-11-26
NL990010I1 (nl) 1999-07-01
NL192739B (nl) 1997-09-01
FR2511679B1 (en:Method) 1985-02-01
IT8222938A1 (it) 1984-02-23
FI73434B (fi) 1987-06-30
LV5511A3 (lv) 1994-03-10
JPH045029B2 (en:Method) 1992-01-30
ZA826120B (en) 1983-07-27
KR840001175A (ko) 1984-03-28
SU1447284A3 (ru) 1988-12-23

Similar Documents

Publication Publication Date Title
ES8400438A1 (es) Procedimiento para preparar derivados de (3h)-imidazo(5,1-d)-1,2,3,5-tetrazin-4-ona.
GR3023219T3 (en) Pyrazolopyridine compounds and processes for preparation thereof
NL980043I1 (nl) Chinoline-tussenprodukten voor de synthese van 1H-imidazoc4,5-c!chinolines en 1H-imidazoc4,5-c!chinoline-4-amine.
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
BG60307B2 (en) Method for obtaining of substituted two-ring compounds
ES8801277A1 (es) Procedimiento para preparar (1,2,4) triazolo (1,5-c) quinazolinas
IE780625L (en) Imidazo-triazines
DE3065304D1 (en) Morpholine derivatives, pharmaceutical compositions containing them and processes for their preparation
AR241531A1 (es) Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables.
YU139587A (en) Process for obtaining derivatives of arylcyclobuthylalkylamine
ATE57919T1 (de) Triazinderivate, verfahren zur herstellung der derivate und die derivate als wirksamen bestandteil enthaltende herbizide.
ATE40358T1 (de) 2,3-dihydrobenzofuran-derivate, mehrere verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
NO167746C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive muramylpeptidderivater.
ZA864235B (en) 1-aryl-5-alkoximinoalkylamino-pyrazoles
ES471239A1 (es) Un metodo para la produccion de compuestos de tiazolidina
ES8801637A1 (es) Un procedimiento para la preparacion de benzimidazoles.
MY103696A (en) Piperazin-l-yl-ergoline derivatives, process for preparing them and pharmaceutical compositions containing them
ES8300776A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina
HUT39968A (en) Herbicide compositions containing thiadiazolyl-oxy-acetamide derivatives as active ingredients and process for preparing the active substances
JPS5432468A (en) Pyrrole derivatives
HUT41615A (en) Fungicidal compositions comprising benzaldoxime carbamate derivatives as active substance and process for preparing such compounds
FR2633622B1 (fr) Derives de sulfonyl indolizine, leur procede de preparation et leur utilisation comme intermediaires de synthese
ES8502981A1 (es) Procedimiento de preparacion de derivados de piperacina.
EP0294828A3 (en) Mitomycin analogs, a process for preparing them and pharmaceutical compositions
ES8105286A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina.

Legal Events

Date Code Title Description
SPCF Request for supplementary protection certificate filed

Free format text: TEMOZOLOMIDE (TEMODAL)

Spc suppl protection certif: C9900027

Filing date: 19990726

SPCG Supplementary protection certificate granted

Free format text: TEMOZOLOMIDE (TEMODAL)

Spc suppl protection certif: C9900027

Filing date: 19990726

Expiry date: 20080719

Effective date: 20020610